English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Patient Daily
| Aug 13, 2024
Patients Come First spokesperson: Medical litigation 'forced many enterprises to shift resources' away from patient care
Martin Hoyt
| Jul 10, 2024
OPINION: Transparency in Medicare: A Necessity for Public Health Reform
Nicholas Malfitano
| Jun 11, 2024
U.S. House Energy and Commerce on Oversight and Investigations Subcommittee Chair Griffith on 340B Program: 'it is not mandated to disclose where these dollars actually go and how much is made from the program'
Patient Daily
| May 31, 2024
US Reps. Bucshon, Carter, Harshbarger introduce legislation for transparency of 340B drug program
Patient Daily
| Mar 30, 2024
Florida Caribbean director: 'They are these incredible ecosystem engineers,'
Patient Daily
| Nov 15, 2023
Penn medicine professor: Level of needed opioid use after a surgery can be determined by ‘a patient’s personal characteristics’.
Patient Daily Report
| Jul 18, 2023
USGS' Smalling: 'The study estimates that at least one type of PFAS ... could be present in nearly half of the tap water in the U.S.'
Patient Daily Report
| Jun 27, 2023
Dr. Peter Marks: 'Today's approval addresses an urgent unmet medical need'
Trending
+
Pharmaceuticals
Patient Daily
| Oct 23, 2025
Empower seeks dismissal of Eli Lilly suit in Texas federal court
Patient Daily
| Oct 23, 2025
Dallas Breathe Free ENT Specialist: Humidity 'tends to help' with sinus issues
Patient Daily
| Oct 23, 2025
Capitol Breathe Free Otolaryngologist: ‘Allergy exacerbations are a common trigger for sinus infections'
+
Pharmaceuticals
Patient Daily
| Oct 29, 2025
Paragon Health Institute senior fellow: 340B program 'needs real reform'
« First
«
1
2
3
4
5
…
»
Last »